News about Genomic test

Institutional November 11 2022 2022-11-14

HER2DX® recognized by TIME as one of the best inventions of 2022

HER2DX® was highlighted in Times 'Medical Care' category, which publicizes inventions that are successfully implemented in medical practice.

Research January 25 2022 2022-01-25

Developed the first genomic test for personalized HER2+ breast cancer treatments

The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.

Research February 6 2021 2021-04-07

The functional genomics platform expands its sequencing capacity with the incorporation of the new NextSeq2000

The new technology will allow researchers to carry out larger studies, with more samples, quickly and with greater sequencing depth at a lower cost.